The transcriptional response of human macrophages to murabutide reflects a spectrum of biological effects for the synthetic immunomodulator

Clinical and Experimental Immunology

Volumn 128, Issue 3, 2002, Pages 474-482

  Goasduff, T ^a,b   Darcissac, E C A ^a,b   Vidal, V ^b   Capron, A ^a   Bahr, G M ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b ISTAC Biotechnologie   (France)

Author keywords

Immunomodulators; Microarray; Monocytes macrophages

Indexed keywords

CARRIER PROTEIN; CELL PROTEIN; GLYCOPEPTIDE; IMMUNOMODULATING AGENT; ION CHANNEL; MATRIX PROTEIN; MURABUTIDE; PHOSPHOTRANSFERASE; PROTEIN INHIBITOR; RNA; TRANSCRIPTION FACTOR;

ARTICLE; BLOOD DONOR; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE PROBE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOMODULATION; MACROPHAGE; MONOCYTE; MULTIGENE FAMILY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RNA ANALYSIS;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; BLOTTING, NORTHERN; CELLS, CULTURED; CHEMOKINES; CYTOKINES; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MACROPHAGES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 0036277792     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01872.x     Document Type: Article

References (42)

1. Molecular portraits of human breast tumours
2. Genomic expression programs in the response of yeast cells to environmental changes
3. Drug target validation and identification of secondary drug target effects using DNA microarrays
4. The interferons. Mechanisms of action and clinical applications
5. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays
6. The role of antimicrobial peptides in animal defenses
7. Serial analysis of gene expression in human monocytes and macrophages
8. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity
9. Stimulation of non-specific resistance to infections by synthetic immunoregulatory agents
10. Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptides
11. Enhancement in vivo of the anti-inflammatory and antitumor activities of type I interferon by association with the synthetic immunomodulator murabutide
12. Enhancement by muramyl peptides of the protective response of interferon-alpha/beta against encephalomyocarditis virus infection
13. Synergistic effects between recombinant interleukin-2 and the synthetic immunomodulator murabutide: Selective enhancement of cytokine release and potentiation of antitumor activity
14. Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine
15. Immunopharmacological activities and clinical development of muramyl peptides with particular emphasis on murabutide
16. Immunological activities of muramyl peptides
17. Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPβ and STAT1: Role of CD14 and Toll-like receptors 2 and 4
18. The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells
19. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines
20. Selective regulation of human immunodeficiency virus-infected CD4 (+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice
21. Selection of a muramyl peptide based on its lack of activation of nuclear factor-kappa B as a potential adjuvant for AIDS vaccines
22. Selective potentiation of cytokine expression in human whole blood by murabutide, a muramyl dipeptide analogue
23. Clinical tolerance and profile of cytokine induction in healthy volunteers following the simultaneous administration of IFN-alpha and the synthetic immunomodulator murabutide
24. Fever: Links with an ancient receptor
25. Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression
26. Mammalian MAP kinase signalling cascades
27. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action
28. Regulation of HIV-1 gene expression
29. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR
30. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells
31. Loss of interferon alpha and interferon tau-induced antiviral protection in interferon regulatory factor-2 DNA-binding domain dominant negative mutants
32. Heat shock protein-peptide complexes as immunotherapy for human cancer
33. Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70
34. Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1
35. Up-regulation of glucose metabolism in Kupffer cells following infusion of tumour necrosis factor
36. Role of glucose in interleukin-1 beta production by lipopolysaccharide-activated human monocytes
37. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo
38. Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection
39. Muramyl peptides as paradigms in neuroimmunomodulation
40. Ninjurin, a novel adhesion molecule, is induced by nerve injury and promotes axonal growth
41. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats
42. Modulation of macrophage and microglial responses to axonal injury in the peripheral and central nervous systems